A polycystás ovarium szindróma a leggyakoribb heterogén endokrin rendellenesség reproduktív korú nőkben. A szindróma továbbra is rejtélyes rendellenesség, amelynek etiológiája még nem tisztázott. Családi előfordulása viszonylag gyakori polycystás ovarium szindrómában szenvedő betegek körében, ami jelentős genetikai komponensre utal, jóllehet, az öröklődés módja nem tisztázott. A szerzők orvosi irodalmi adatok alapján áttekintették a genetikai és környezeti tényezők szerepét a polycystás ovarium szindróma kialakulásában. A mai napig még nem azonosítottak olyan gént, ami okozza vagy jelentős mértékben hozzájárul a kórkép fenotípusának kialakításához. A polycystás ovarium szindrómát olyan genetikai rendellenességnek kell tekinteni, amelyben számos genetikai és környezeti tényező kölcsönhatása határozza meg a heterogén klinikai és biokémiai fenotípust. Összefoglalva a jelenlegi bizonyítékokat, a szerzők arra a következtetésre jutottak, hogy a környezeti tényezők azonosítása és módosítása lehetségessé teszi azon személyek egészségének hatékonyabb védelmét, akiknél a genotípus vagy korábbi környezeti hatások hajlamosítanak a betegség kifejlődésére. Orv. Hetil., 2013, 154, 650–657.
Tfayli, H., Arslanian, S.: Menstrual health and the metabolic syndrome in adolescents. Ann. N. Y. Acad. Sci., 2008, 1135, 85–94.
Arslanian S. , 'Menstrual health and the metabolic syndrome in adolescents ' (2008 ) 1135 Ann. N. Y. Acad. Sci. : 85 -94.
Nicandri, K. F., Hoeger, K.: Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Curr. Opin. Endocrinol. Diabetes Obes., 2012, 19, 497–504.
Hoeger K. , 'Diagnosis and treatment of polycystic ovarian syndrome in adolescents ' (2012 ) 19 Curr. Opin. Endocrinol. Diabetes Obes. : 497 -504.
Aggoun, Y.: Obesity, metabolic syndrome, and cardiovascular disease. Pediatr. Res., 2007, 61, 653–659.
Aggoun Y. , 'Obesity, metabolic syndrome, and cardiovascular disease ' (2007 ) 61 Pediatr. Res. : 653 -659.
Eriksson, J., Forsén, T., Osmond, C., et al.: Obesity from cradle to grave. Int. J. Obes. Relat. Metab. Disord., 2003, 27, 722–727.
Osmond C. , 'Obesity from cradle to grave ' (2003 ) 27 Int. J. Obes. Relat. Metab. Disord. : 722 -727.
Carmina, E.: PCOS: metabolic impact and long-term management. Minerva Ginecol., 2012, 64, 501–516.
Carmina E. , 'PCOS: metabolic impact and long-term management ' (2012 ) 64 Minerva Ginecol. : 501 -516.
Teede, H., Deeks, A., Moran, L.: Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med., 2010, 8, 41.
Moran L. , 'Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan ' (2010 ) 8 BMC Med. : 41 -.
Motta, A. B.: The role of obesity in the development of polycystic ovary syndrome. Curr. Pharm. Des., 2012, 18, 2482–2491.
Motta A. B. , 'The role of obesity in the development of polycystic ovary syndrome ' (2012 ) 18 Curr. Pharm. Des. : 2482 -2491.
Norman, R. J., Dewailly, D., Legro, R. S., et al.: Polycystic ovary syndrome. Lancet, 2007, 370, 685–697.
Legro R. S. , 'Polycystic ovary syndrome ' (2007 ) 370 Lancet : 685 -697.
Sam, S., Legro, R. S., Essah, P., et al.: Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA, 2006, 103, 7030–7035.
Essah P. , 'Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome ' (2006 ) 103 Proc. Natl. Acad. Sci. USA : 7030 -7035.
March, W. A., Moore, V. M., Willson, K. J., et al.: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod., 2010, 25, 544–551.
Willson K. J. , 'The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria ' (2010 ) 25 Hum. Reprod. : 544 -551.
Williams, R. M., Ong, K. K., Dunger, D. B.: Polycystic ovarian syndrome during puberty and adolescence. Mol. Cell. Endocrinol., 2013 Feb 4. pii: S0303-7207(13)00028-2 . doi: 10.1016/j.mce.2013.01.005 . [Epub ahead of print]
Legro, R. S., Strauss, J. F.: Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril., 2002, 78, 569–576.
Strauss J. F. , 'Molecular progress in infertility: polycystic ovary syndrome ' (2002 ) 78 Fertil Steril. : 569 -576.
Diamanti-Kandarakis, E., Kandarakis, H., Legro, R. S.: The role of genes and environment in the etiology of PCOS. Endocrine, 2006, 30, 19–26.
Legro R. S. , 'The role of genes and environment in the etiology of PCOS ' (2006 ) 30 Endocrine : 19 -26.
Urbanek, M., Legro, R. S., Driscoll, D. A., et al.: Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. USA, 1999, 96, 8573–8578.
Driscoll D. A. , 'Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin ' (1999 ) 96 Proc. Natl. Acad. Sci. USA : 8573 -8578.
Xita, N., Georgiou, I., Tsatsoulis, A.: The genetic basis of polycystic ovary syndrome. Eur. J. Endocrinol., 2002, 147, 717–725.
Tsatsoulis A. , 'The genetic basis of polycystic ovary syndrome ' (2002 ) 147 Eur. J. Endocrinol. : 717 -725.
Diamanti-Kandarakis, E., Papavassiliou, A. G.: Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol. Med., 2006, 12, 324–332.
Papavassiliou A. G. , 'Molecular mechanisms of insulin resistance in polycystic ovary syndrome ' (2006 ) 12 Trends Mol. Med. : 324 -332.
Daneshmand, S., Weitsman, S. R., Navab, A., et al.: Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters. Fertil. Steril., 2002, 77, 274–280.
Navab A. , 'Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters ' (2002 ) 77 Fertil. Steril. : 274 -280.
Strauss, J. F. 3rd.: Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann. N. Y. Acad. Sci., 2003, 997, 42–48.
Strauss J. F. , 'Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome ' (2003 ) 997 Ann. N. Y. Acad. Sci. : 42 -48.
Urbanek, M., Wu, X., Vickery, K. R., et al.: Allelic variants of the follistatin gene in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2000, 85, 4455–4461.
Vickery K. R. , 'Allelic variants of the follistatin gene in polycystic ovary syndrome ' (2000 ) 85 J. Clin. Endocrinol. Metab. : 4455 -4461.
Barker, D. J., Forsén, T., Uutela, A., et al.: Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study. BMJ, 2001, 323, 1273–1276.
Uutela A. , 'Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study ' (2001 ) 323 BMJ : 1273 -1276.
Singhal, A., Fewtrell, M., Cole, T. J., et al.: Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet, 2003, 361, 1089–1097.
Cole T. J. , 'Low nutrient intake and early growth for later insulin resistance in adolescents born preterm ' (2003 ) 361 Lancet : 1089 -1097.
Maciel, G. A., Baracat, E. C., Benda, J. A., et al.: Stockpiling of transitional and classic primary follicules in ovaries of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2004, 89, 5321–5327.
Benda J. A. , 'Stockpiling of transitional and classic primary follicules in ovaries of women with polycystic ovary syndrome ' (2004 ) 89 J. Clin. Endocrinol. Metab. : 5321 -5327.
Hogg, K., McNeilly, A. S., Duncan, W. C.: Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology, 2011, 152, 2048–2059.
Duncan W. C. , 'Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary ' (2011 ) 152 Endocrinology : 2048 -2059.
Hogg, K., Young, J. M., Oliver, E. M., et al.: Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology, 2012, 153, 450–461.
Oliver E. M. , 'Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome ' (2012 ) 153 Endocrinology : 450 -461.
Franasiak, J., Young, S. L., Williams, C. D., et al.: Longitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial. Evid Based Complement Alternat Med., 2012, 2012, 973712.
Williams C. D. , 'Longitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial ' (2012 ) 2012 Evid Based Complement Alternat Med. : 973712 -.
Károlyi, Z.: The pathomechanism of polycystic ovary syndrome in the light of recent research findings. [A polycystás ovarium szindróma kialakulásáról az újabb kutatások fényében.] Orv. Hetil., 2012, 153, 1567–1569. [Hungarian]
Károlyi Z. , 'The pathomechanism of polycystic ovary syndrome in the light of recent research findings. [A polycystás ovarium szindróma kialakulásáról az újabb kutatások fényében.] ' (2012 ) 153 Orv. Hetil. : 1567 -1569.
Franks, S., Webber, L. J., Goh, M., et al.: Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J. Clin. Endocrinol. Metab., 2008, 93, 3396–3402.
Goh M. , 'Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries ' (2008 ) 93 J. Clin. Endocrinol. Metab. : 3396 -3402.
Holemans, K., Aerts, L., Van Assche, F. A.: Fetal growth restriction and consequences for the offspring in animal models. J. Soc. Gynecol. Investig., 2003, 10, 392–399.
Assche F. A. , 'Fetal growth restriction and consequences for the offspring in animal models ' (2003 ) 10 J. Soc. Gynecol. Investig. : 392 -399.
Heber, M. F., Vélez, L. M., Ferreira, S. R., et al.: The role of prenatal hyperandrogenism on lipid metabolism during adult life in a rat model. Medicina (B. Aires), 2012, 72, 389–392.
Ferreira S. R. , 'The role of prenatal hyperandrogenism on lipid metabolism during adult life in a rat model ' (2012 ) 72 Medicina (B. Aires) : 389 -392.
Davies, M. J., March, W. A., Willson, K. J., et al.: Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood. Hum. Reprod., 2012, 27, 1475–1480.
Willson K. J. , 'Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood ' (2012 ) 27 Hum. Reprod. : 1475 -1480.
Mumm, H., Kamper-Jørgensen, M., Nybo Andersen, A. M., et al.: Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973–1991. Fertil. Steril., 2012 Nov 29. pii: S0015-0282(12)02398-9 .. doi: 10.1016/j.fertnstert.2012.11.004 . [Epub ahead of print]
Ilyés, I.: Insulin resistance in children born with weight and/or height low for gestational age. [A gesztációs idejükhöz viszonyítva kis súllyal és/vagy hosszal született gyerekek inzulinrezisztenciája.] Metabolizmus, 2012, 10, 157–159. [Hungarian]
Ilyés I. , 'Insulin resistance in children born with weight and/or height low for gestational age. [A gesztációs idejükhöz viszonyítva kis súllyal és/vagy hosszal született gyerekek inzulinrezisztenciája.] ' (2012 ) 10 Metabolizmus : 157 -159.
Sir-Petermann, T., Ladrón de Guevara, A., Villarroel, A. C., et al.: Polycystic ovary syndrome and pregnancy. Rev. Med. Chil., 2012, 140, 919–925.
Villarroel A. C. , 'Polycystic ovary syndrome and pregnancy ' (2012 ) 140 Rev. Med. Chil. : 919 -925.
Pasquali, R., Gambineri, A.: Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann. N. Y. Acad. Sci., 2006, 1092, 158–174.
Gambineri A. , 'Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age ' (2006 ) 1092 Ann. N. Y. Acad. Sci. : 158 -174.
Alvarez-Blasco, F., Botella-Carretero, J. I., San Millán, J. L., et al.: Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch. Intern. Med., 2006, 166, 2081–2086.
Millán J. L. , 'Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women ' (2006 ) 166 Arch. Intern. Med. : 2081 -2086.
Longo, S., Bollani, L., Decembrino, L., et al.: Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J. Matern. Fetal Neonatal Med., 2013, 26, 222–225.
Decembrino L. , 'Short-term and long-term sequelae in intrauterine growth retardation (IUGR) ' (2013 ) 26 J. Matern. Fetal Neonatal Med. : 222 -225.
Melo, A. S., Vieira, C. S., Barbieri, M. A., et al.: High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum. Reprod., 2010, 25, 2124–2131.
Barbieri M. A. , 'High prevalence of polycystic ovary syndrome in women born small for gestational age ' (2010 ) 25 Hum. Reprod. : 2124 -2131.
Mehrabian, F., Kelishadi, R.: Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls. J. Res. Med. Sci., 2012, 17, 207–211.
Kelishadi R. , 'Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls ' (2012 ) 17 J. Res. Med. Sci. : 207 -211.
Barker, D. J., Winter, P. D., Osmond, C., et al.: Weight in infancy and death from ischaemic heart disease. Lancet, 1989, 334, 577–580.
Osmond C. , 'Weight in infancy and death from ischaemic heart disease ' (1989 ) 334 Lancet : 577 -580.
Barker, D. J., Hales, C. N., Fall, C. H., et al.: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia, 1993, 36, 62–67.
Fall C. H. , 'Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth ' (1993 ) 36 Diabetologia : 62 -67.
Dyer, J. S., Rosenfeld, C. R.: Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. Semin. Reprod. Med., 2011, 29, 266–276.
Rosenfeld C. R. , 'Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review ' (2011 ) 29 Semin. Reprod. Med. : 266 -276.
Dover, G. J.: The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases. Trans. Am. Clin. Climatol. Assoc., 2009, 120, 199–207.
Dover G. J. , 'The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases ' (2009 ) 120 Trans. Am. Clin. Climatol. Assoc. : 199 -207.
Jaquet, D., Deghmoun, S., Chevenne, D., et al.: Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia, 2005, 48, 849–855.
Chevenne D. , 'Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth ' (2005 ) 48 Diabetologia : 849 -855.
Forsén, T., Eriksson, J. G., Tuomilehto, J., et al.: Mother’s weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ, 1997, 315, 837–840.
Tuomilehto J. , 'Mother’s weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study ' (1997 ) 315 BMJ : 837 -840.
Hattersley, A. T., Tooke, J. E.: The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet, 1999, 353, 1789–1792.
Tooke J. E. , 'The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease ' (1999 ) 353 Lancet : 1789 -1792.
Gluckman, P. D., Pinal, C. S.: Regulation of fetal growth by the somatotrophic axis. J. Nutr., 2003, 133 (5 Suppl. 2), 1741S–1746S.
Pinal C. S. , 'Regulation of fetal growth by the somatotrophic axis ' (2003 ) 133 J. Nutr. : 1741S -1746S.
Vickers, M. H., Breier, B. H., McCarthy, D., et al.: Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 285, R271–R273.
McCarthy D. , 'Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition ' (2003 ) 285 Am. J. Physiol. Regul. Integr. Comp. Physiol. : R271 -R273.
Hales, C. N., Barker, D. J.: The thrifty phenotype hypothesis. Br. Med. Bull., 2001, 60, 5–20.
Barker D. J. , 'The thrifty phenotype hypothesis ' (2001 ) 60 Br. Med. Bull. : 5 -20.
Fall, C. H. D.: Childhood weight gain and the adiposity rebound. In: Brook, C. G. D. (ed.): Clinical pediatric endocrinology. Blackwell Publishing, 2006, 396–399.
Fall C. H. D. , '', in Clinical pediatric endocrinology , (2006 ) -.
Reik, W., Constância, M., Fowden, A., et al.: Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J. Physiol., 2003, 547 (Pt 1), 35–44.
Fowden A. , 'Regulation of supply and demand for maternal nutrients in mammals by imprinted genes ' (2003 ) 547 J. Physiol. : 35 -44.
Lester, B. M., Tronick, E., Nestler, E., et al.: Behavioral epigenetics. Ann. N. Y. Acad. Sci., 2011, 1226, 14–33.
Nestler E. , 'Behavioral epigenetics ' (2011 ) 1226 Ann. N. Y. Acad. Sci. : 14 -33.
Dumesic, D. A., Abbott, D. H., Padmanabhan, V.: Polycystic ovary syndrome and its developmental origins. Rev. Endocr. Metab. Disord., 2007, 8, 127–141.
Padmanabhan V. , 'Polycystic ovary syndrome and its developmental origins ' (2007 ) 8 Rev. Endocr. Metab. Disord. : 127 -141.
Poulsen, P., Vaag, A. A., Kyvik, K. O., et al.: Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia, 1997, 40, 439–446.
Kyvik K. O. , 'Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs ' (1997 ) 40 Diabetologia : 439 -446.
Phillips, D. I., Davies, M. J., Robinson, J. S.: Fetal growth and the fetal origins hypothesis in twins – problems and perspectives. Twin Res., 2001, 4, 327–331.
Robinson J. S. , 'Fetal growth and the fetal origins hypothesis in twins – problems and perspectives ' (2001 ) 4 Twin Res. : 327 -331.
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., et al.: Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study. J. Clin. Endocrinol. Metab., 2006, 91, 2100–2104.
Lambalk C. B. , 'Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 2100 -2104.
Kosova, G., Urbanek, M.: Genetics of the polycystic ovary syndrome. Mol. Cell. Endocrinol., 2012 Oct 16. pii: S0303-7207(12)00461-3 .. doi: 10.1016/j.mce.2012.10.009 . [Epub ahead of print]
Urbanek, M.: The genetics of the polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab., 2007, 3, 103–111.
Urbanek M. , 'The genetics of the polycystic ovary syndrome ' (2007 ) 3 Nat. Clin. Pract. Endocrinol. Metab. : 103 -111.
Franks, S., McCarthy, M.: Genetics of ovarian disorders: polycystic ovary syndrome. Rev. Endocr. Metab. Disord., 2004, 5, 69–76.
McCarthy M. , 'Genetics of ovarian disorders: polycystic ovary syndrome ' (2004 ) 5 Rev. Endocr. Metab. Disord. : 69 -76.
Franks, S., Berga, S. L.: Does PCOS have developmental origins? Fertil. Steril., 2012, 97, 2–6.
Berga S. L. , 'Does PCOS have developmental origins? ' (2012 ) 97 Fertil. Steril. : 2 -6.
Demissie, M., Lazic, M., Foecking, E. M., et al.: Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am. J. Physiol. Endocrinol. Metab., 2008, 295, E262–E268.
Foecking E. M. , 'Transient prenatal androgen exposure produces metabolic syndrome in adult female rats ' (2008 ) 295 Am. J. Physiol. Endocrinol. Metab. : E262 -E268.
Moran, L. J., Pasquali, R., Teede, H. J., et al.: Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil. Steril., 2009, 92, 1966–1982.
Teede H. J. , 'Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society ' (2009 ) 92 Fertil. Steril. : 1966 -1982.
Cole, B., Hensinger, K., Maciel, G. A., et al.: Human fetal ovary development involves the spatiotemporal expression of p450c17 protein. J. Clin. Endocrinol. Metab., 2006, 91, 3654–3661.
Maciel G. A. , 'Human fetal ovary development involves the spatiotemporal expression of p450c17 protein ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 3654 -3661.
Fowler, P. A., Anderson, R. A., Saunders, P. T., et al.: Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. J. Clin. Endocrinol. Metab., 2011, 96, 1754–1762.
Saunders P. T. , 'Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary ' (2011 ) 96 J. Clin. Endocrinol. Metab. : 1754 -1762.
Sir-Petermann, T., Codner, E., Pérez, V., et al.: Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2009, 94, 1923–1930.
Pérez V. , 'Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome ' (2009 ) 94 J. Clin. Endocrinol. Metab. : 1923 -1930.
Geier, L. M., Bekx, M. T., Connor, E. L.: Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol., 2012, 25, 367–370.
Connor E. L. , 'Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome ' (2012 ) 25 J. Pediatr. Adolesc. Gynecol. : 367 -370.
Poomthavorn, P., Chaya, W., Mahachoklertwattana, P., et al.: Glucose metabolism in obese and lean adolescents with polycystic ovary syndrome.; J. Pediatr. Endocrinol. Metab., 2013 Jan 12, 1–6. doi: 10.1515/jpem-2012-0328 . [Epub ahead of print]
Barber, T. M., Franks, S.: Adipocyte biology in polycystic ovary syndrome. Mol. Cell. Endocrinol., 2012 Oct 17. pii: S0303-7207(12)00462-5 .. doi: 10.1016/j.mce.2012.10.010 . [Epub ahead of print]
Pinola, P., Lashen, H., Bloigu, A., et al.: Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum. Reprod., 2012, 27, 3279–3286.
Bloigu A. , 'Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study ' (2012 ) 27 Hum. Reprod. : 3279 -3286.
Li, L., Chen, X., He, Z., et al.: Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J. Pediatr. Adolesc. Gynecol., 2012, 25, 390–395.
He Z. , 'Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents ' (2012 ) 25 J. Pediatr. Adolesc. Gynecol. : 390 -395.
Markopoulos, M. C., Valsamakis, G., Kouskouni, E., et al.: Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause. Eur. J. Endocrinol., 2012, 168, 83–90.
Kouskouni E. , 'Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause ' (2012 ) 168 Eur. J. Endocrinol. : 83 -90.
Coviello, A. D., Legro, R. S., Dunaif, A.: Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab., 2006, 91, 492–497.
Dunaif A. , 'Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 492 -497.
O’Meara, N. M., Blackman, J. D., Ehrmann, D. A., et al.: Defects in beta-cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 1993, 76, 1241–1247.
Ehrmann D. A. , 'Defects in beta-cell function in functional ovarian hyperandrogenism ' (1993 ) 76 J. Clin. Endocrinol. Metab. : 1241 -1247.
Dunaif, A., Segal, K. R., Futterweit, W., et al.: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 1989, 38, 1165–1174.
Futterweit W. , 'Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome ' (1989 ) 38 Diabetes : 1165 -1174.
Robinson, S., Kiddy, D., Gelding, S. V., et al.: The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. (Oxf.), 1993, 39, 351–355.
Gelding S. V. , 'The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries ' (1993 ) 39 Clin. Endocrinol. (Oxf.) : 351 -355.
Jovanovic, V. P., Carmina, E., Lobo, R. A.: Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertil. Steril., 2010, 94, 826–832.
Lobo R. A. , 'Not all women diagnosed with PCOS share the same cardiovascular risk profiles ' (2010 ) 94 Fertil. Steril. : 826 -832.
Marshall, J. C., Dunaif, A.: Should all women with PCOS be treated for insulin resistance? Fertil. Steril., 2012, 97, 18–22.
Dunaif A. , 'Should all women with PCOS be treated for insulin resistance? ' (2012 ) 97 Fertil. Steril. : 18 -22.
Okoroh, E. M., Hooper, W. C., Atrash, H. K., et al.: Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008. Am. J. Obstet. Gynecol., 2012, 207, 299, e1–e7.
Atrash H. K. , 'Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008 ' (2012 ) 207 Am. J. Obstet. Gynecol. : 299, e1 -e7.
Roe, A. H., Prochaska, E., Smith, M., et al.: Using the Androgen Excess-PCOS Society Criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J. Pediatr., 2012 Dec 19. pii: S0022-3476(12)01313-3 .. doi: 10.1016/j.jpeds.2012.11.019 . [Epub ahead of print]
Palmert, M. R., Gordon, C. M., Kartashov, A. I., et al.: Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2002, 87, 1017–1023.
Kartashov A. I. , 'Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome ' (2002 ) 87 J. Clin. Endocrinol. Metab. : 1017 -1023.
Salley, K. E., Wickham, E. P., Cheang, K. I., et al.: Glucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess Society. J. Clin. Endocrinol. Metab., 2007, 92, 4546–4556.
Cheang K. I. , 'Glucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess Society ' (2007 ) 92 J. Clin. Endocrinol. Metab. : 4546 -4556.
Vilmann, L. S., Thisted, E., Baker, J. L., et al.: Development of obesity and polycystic ovary syndrome in adolescents. Horm. Res. Paediatr., 2012, 78, 269–278.
Baker J. L. , 'Development of obesity and polycystic ovary syndrome in adolescents ' (2012 ) 78 Horm. Res. Paediatr. : 269 -278.
Jakubowski, K. P., Black, J. J., El Nokali, N. E., et al.: Parents’ readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome. J. Obes., 2012, 2012, 298067.
Nokali N. E. , 'Parents’ readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome ' (2012 ) 2012 J. Obes. : 298067 -.
Wang, Y., Ge, K., Popkin, B. M.: Tracking of body mass index from childhood to adolescence: a 6-y follow-up study in China. Am. J. Clin. Nutr., 2000, 72, 1018–1024.
Popkin B. M. , 'Tracking of body mass index from childhood to adolescence: a 6-y follow-up study in China ' (2000 ) 72 Am. J. Clin. Nutr. : 1018 -1024.